Cargando…

P960: HEALTH-RELATED QUALITY OF LIFE IN THE LOCOMMOTION STUDY OF REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales:	Delforge, M., Moreau, P., Einsele, H., De Stefano, V., Lindsey-Hill, J., Vincent, L., Mangiacavalli, S., Perrot, A., Ocio, E., ten Seldam, S., ’. Groen-Damen, E. I., Semerjian, M., Strulev, V., Schecter, J. M., Roccia, T., Gries, K. S., Nesheiwat, T., Wapenaar, R., Mateos, M.-V., Weisel, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430073/ http://dx.doi.org/10.1097/01.HS9.0000846708.96708.ff

Ejemplares similares

P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSES FROM THE LOCOMMOTION STUDY
por: Einsele, H., et al.
Publicado: (2022)

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
por: Mateos, Maria-Victoria, et al.
Publicado: (2022)

P904: LOCOMMOTION: A PROSPECTIVE, OBSERVATIONAL, MULTINATIONAL STUDY OF REAL-LIFE CURRENT STANDARDS OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA– FINAL ANALYSIS AT 2-YEAR FOLLOW-UP
por: Moreau, Philippe, et al.
Publicado: (2023)

P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
por: Weisel, K., et al.
Publicado: (2022)

P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Moreau, Philippe, et al.
Publicado: (2023)

Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma
por: Moreau, Philippe, et al.
Publicado: (2023)

Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice
por: Mateos, Maria-Victoria, et al.
Publicado: (2022)

P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Einsele, Hermann, et al.
Publicado: (2023)

P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL-WORLD CLINICAL PRACTICE: TWO-YEAR FOLLOW-UP ANALYSES FROM CARTITUDE-1 AND THE PROSPECTIVE LOCOMMOTION STUDY
por: Mateos, Maria-Victoria, et al.
Publicado: (2023)

P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY
por: Einsele, H., et al.
Publicado: (2022)

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
por: Hillengass, J., et al.
Publicado: (2022)

P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY
por: Einsele, H, et al.
Publicado: (2022)

Klaviersonate D 960 op. 15 / Robert Schumann.
por: Schubert, Franz, 1797-1828
Publicado: (1990)

CERN Courier Archive: I960
Publicado: (2004)

CERN Courier Archive: I960
Publicado: (2004)

Sonata in B-flat, D. 960 /
por: Schubert, Franz, 1797-1828
Publicado: (1991)

Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany
por: Schmidt, Andreas, et al.
Publicado: (2023)

Piano sonatas D. 960, D. 958
por: Schubert, Franz, 1797-1828
Publicado: (1994)

Piano sonatas D960 & D664
por: Schubert, Franz, 1797-1828
Publicado: (1994)

Research of the Fatigue Life of Welded Joints of High Strength Steel S960 QL Created Using Laser and Electron Beams
por: Sága, Milan, et al.
Publicado: (2020)

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL
por: Facon, T., et al.
Publicado: (2023)

Search for negatively charged meson near 960 MeV
por: Barloutaud, R, et al.
Publicado: (1968)

POS-960 ASSOCIATION OF PARATHYROID HORMONE LEVEL WITH SEVERITY OF CORONAVIRUS-INDUCED PNEUMONIA IN HEMODIALYSIS PATIENTS
por: Rysyev, A., et al.
Publicado: (2022)

Determination of Grain Growth Kinetics of S960MC Steel
por: Mičian, Miloš, et al.
Publicado: (2022)

Exome sequencing and characterization of 49,960 individuals in the UK Biobank
por: Van Hout, Cristopher V., et al.
Publicado: (2020)

960. Implementation and Evaluation of Alcohol Screening Tool in HIV Patients
por: Brickner, Evan D, et al.
Publicado: (2020)

Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
por: Perrot, Aurore, et al.
Publicado: (2021)

A flourishing yin: gender in China's medical history, 960–1665
por: Wood, Frances
Publicado: (2000)

B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
por: Gay, F, et al.
Publicado: (2022)

Dataset on full width at half maximum of residual stress measurement of electron beam welded high strength structural steels (S960QL and S960M) by X-ray diffraction method
por: Sisodia, Raghawendra P.S., et al.
Publicado: (2021)

Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System
por: Koh, Won-Jung, et al.
Publicado: (2012)

Re-Evaluation of the Critical Concentration for Ethambutol Antimicrobial Sensitivity Testing on the MGIT 960
por: Christianson, Sara, et al.
Publicado: (2014)

In Vitro Antimycobacterial Activity of Pakistani Beri Honey Using BACTEC MGIT 960
por: Hannan, Abdul, et al.
Publicado: (2014)

Treatment algorithm in 960 pediatric burn cases: A review of etiology and epidemiology
por: Avci, Veli, et al.
Publicado: (2018)

Reprocessing of Contaminated MGIT 960 Cultures to Improve Availability of Valid Results for Mycobacteria
por: Subramanyam, Balaji, et al.
Publicado: (2020)

Safety of the proposed amendment of the specifications of the food additive steviol glycosides (E 960)
por: Younes, Maged, et al.
Publicado: (2018)

Influence of LWE on Strength of Welded Joints of HSS S960—Experimental and Numerical Analysis
por: Dzioba, Ihor, et al.
Publicado: (2020)

Histopathological features in the clinical specimens with tuberculosis diagnosis by BACTEC MGIT 960 culture
por: Cuong, Nguyen Kim, et al.
Publicado: (2023)

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer
por: Klauck, Peter J., et al.
Publicado: (2018)

The half-life of $^{221}$Fr in Si and Au at 4K and at mK temperatures
por: Wauters, F., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0aouqghtpmh6paiheiagh0qm8s